Genedrive is pharmacogenetic testing company focused on developing and commercialising low cost, rapid point-of-care tests to enable precision-based medicine and optimize patient outcomes, particularly in time-critical emergency settings. Its CE-marked CYP2C19 test, validated in collaboration with NHS, addresses critical needs in stroke care.
Gino Miele
CEO
Russ Shaw
CFO
thematic
Consumer
thematic
Energy & Resources